JOHNSON & JOHNSON
Public company- Headquarters
- NEW BRUNSWICK, New Jersey
- Ticker
- JNJ
- CIK
- 0000200406
WARN notices since 2024
3
First: Dec 27, 2024
Workers affected since 2024
405
Across 3 notices
Executive changes, last 12 months
1
0 appointments, 1 departure
Last event
Nov 7, 2026
WARN noticeWARN notice: New Brunswick, NJ
Workers affected over time
Cumulative workers in WARN notices since 2024
| Notice date | Workers affected | Cumulative |
|---|---|---|
| Dec 27, 2024 | 231 | 231 |
| Aug 21, 2026 | 86 | 317 |
| Nov 7, 2026 | 88 | 405 |
Leadership
| Role and person | Since | Change |
|---|---|---|
| Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive CommitteeJennifer Taubert | Aug 4, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- ELITE PHARMACEUTICALS INC /NV/
Class I director appointed: John W. LaRocca, Esq.
- INSMED Inc
Class II director appointed: Paul Hudson
- Executive departure
Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee departs: Jennifer Taubert
Jennifer Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee of JOHNSON & JOHNSON, retires the role, effective September 1, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 4, 2026Role: Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee
Last verified Nov 8, 2026